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ABSTRACT
Background: As the population ages, it is increasingly important to use effective short cognitive tests for
suspected dementia. We aimed to review systematically brief cognitive tests for suspected dementia and
report on their validation in different settings, to help clinicians choose rapid and appropriate tests.
Methods: Electronic search for face-to-face sensitive and specific cognitive tests for people with suspected
dementia, taking  20 minutes, providing quantitative psychometric data.
Results: 22 tests fitted criteria. Mini-Mental State Examination (MMSE) and Hopkins Verbal Learning Test
(HVLT) had good psychometric properties in primary care. In the secondary care settings, MMSE has
considerable data but lacks sensitivity. 6-Item Cognitive Impairment Test (6CIT), Brief Alzheimer’s Screen,
HVLT, and 7 Minute Screen have good properties for detecting dementia but need further validation.
Addenbrooke’s Cognitive Examination (ACE) and Montreal Cognitive Assessment are effective to detect
dementia with Parkinson’s disease and Addenbrooke’s Cognitive Examination-Revised (ACE-R) is useful for
all dementias when shorter tests are inconclusive. Rowland Universal Dementia Assessment scale (RUDAS) is
useful when literacy is low. Tests such as Test for Early Detection of Dementia, Test YourMemory, Cognitive
Assessment Screening Test (CAST) and the recently developed ACE-III show promise but need validation in
different settings, populations, and dementia subtypes. Validation of tests such as 6CIT, Abbreviated Mental
Test is also needed for dementia screening in acute hospital settings.
Conclusions: Practitioners should use tests as appropriate to the setting and individual patient. More validation
of available tests is needed rather than development of new ones.
Key words: Dementia, brief cognitive tests, cognitive screen, cognitive screening tests
Introduction
Cognitive impairment is a core and usually first
symptom of dementia (APA, 1994). Efficient early
diagnosis of those with suspected dementia requires
quick, meaningful cognitive tests. The International
Psychogeriatric Association survey found 20 brief
cognitive instruments which respondents used in
clinical practice chosen for “effectiveness,” “ease
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of administration,” and “familiarity” (Shulman
et al., 2006). The Mini-Mental State Examination
(MMSE) was the commonest, followed by the
Clock Drawing Test (CDT).
Brief cognitive tests are part of the armoury
required to help confirm suspected dementia and
should be quick, easy, and acceptable with a high
positive likelihood ratio (LR), so clinicians will be
less likely to misidentify a patient with dementia.
LRs are used for assessing a diagnostic test (Smith,
2009). The LR positive (LR+) is calculated as
sensitivity/1-specificity and LR negative (LR−) =
1 − sensitivity/specificity. A likelihood ratio (LR)
>1 indicates the test is associated with the disease
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(LR+), and < 1 indicates association with its
absence (LR−).
There have been several narrative reviews of
tests, for example, for primary care (Milne et al.,
2008). A review of the diagnostic accuracy of longer
(up to 45minutes) tests could not identify a superior
instrument (Appels and Scherder, 2010). A meta-
analysis identified 15 brief cognitive tests which
were less accurate than the MMSE in detecting
dementia in community and primary care settings
but had similar accuracy in specialist settings
(Mitchell and Malladi, 2010a). Another meta-
analysis examined diagnostic validity of 29 brief
multi-domain screening methods and suggested
alternatives tests with favourable rule-in and rule-
out accuracy (Mitchell and Malladi, 2010b).
However, it included tests only if administered in
<10 minutes and with validation in studies with
more than 170 patients. We know of no review
that uses evidence-based criteria to categorize tests
according to the confidence with which they can be
used in the setting for which they were designed.
Our aim in this review was to identify brief
cognitive tests for people with suspected dementia,
and determine their level and quality of evidence in
clinical settings and the types of dementia for which
they are validated, in order to help clinicians choose
a valid, reliable, rapid, and appropriate test most
suitable for their setting. It was carried out using
similar methods as earlier systematic reviews from
our group (Cooper et al., 2011; Livingston et al.,
2005).
Methods
Eligibility characteristics, information
sources, and search strategy
We searched electronic databases Medline (1990–
May 2013), Embase (1974–May 2013), PsychInfo
(1990–May 2013), Web of Science (1990–
2004), HMIC Health Management Information
Consortium (1979 to March 2013) and the
Cochrane library (1990–2010) for English language
papers using key words—“dementia, brief cognitive
tests, cognitive screen” and reference lists from
included and review articles. Additionally, we
hand-searched the International Journal of Geriatric
Psychiatry, Ageing and Mental Health, International
Psychogeriatrics, and Age and Aging.
Selection criteria
We included instruments used for patients with
any suspected dementia; performed solely face
to face with the patient; taking  20 minutes
with quantitative psychometric data and validation
against dementia diagnosis (without excluding
mild dementia) to include tests suitable for
secondary care. We excluded tests with functional
and behavioral items; telephonic or computerized
self-tests, informant’s questionnaires; detecting
dementia praecox or dementia secondary to head
injury; or mild cognitive impairment (MCI)
without dementia; studies in people without
dementia (unless people with dementia were
analyzed separately); those to measure cognition
in moderate to severe dementia rather than for
suspected dementia, tested in learning disability
population; qualitative tests; non-English language
tests; translated versions. We also excluded tests
which validation was only against other cognitive
tests and those without a means of scoring for
clinical practice, with no cut-off scores.
Data extraction, quality assessment, and
summary measures
Three authors, working in pairs (LV, SR, MR,
MC) independently reviewed titles and abstracts for
inclusion criteria. Whenever they disagreed, the full
paper was reviewed with the senior author (GL).
All included papers were then reread by LV, GL,
or MP to ensure that they were validated against
suitable criteria. We extracted data: (population,
recruitment strategy, specification of illness, study
design, purpose of the test, time taken to
apply, total items, total scores, cut-off score,
sensitivity, specificity, validity, reference standard,
and blinding) and used a checklist for evaluating
diagnostic tests (Table 1) (Whiting et al., 2004).
Three authors assessed study quality independ-
ently using CEBM guideline (LV, MR, SR). The
senior author (GL) reviewed any disagreements.
The level of evidence and grades of evidence were
then assigned from standard guidelines according to
the Oxford Evidence-basedMedicine Centre http://
www.cebm.net/index.aspx?o= 5653 (Howick et al.,
2011). Levels of evidence (LE) ranged from one to
five, with lower numbers indicating higher quality
(Appendix S1). We report sensitivity, specificity
and positive and negative likelihood ration where
calculable or reported. Excluded tests with rationale
are inTable S1. (seeTable S1, FigS1, andAppendix
S1 available as supplementary material attached to
the electronic version of this paper at www.journals.
cambridge.org/jid_IPG).
Results
Study selection
We identified 22 tests in the 2928 references which
met inclusion criteria (Figure S1-prisma flow chart).
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Table 1. Brief cognitive tests for dementia (Arranged by the level of evidence)
SOURCE POPULATION, COUNTRY
STUDY
DESIGN
COGNITIVE
TEST ILLNESS REFERENCE STANDARD
LOE
(2011)
............................................................................................................................................................................................................................................................................................................................................................................................................................................................
Crawford et al. (2012) Primary and secondary care Systematic
review
ACE/ACE-R Dementia NINCDS-ADRDA, CDR 1
Grober et al. (2010) Primary care, USA Prospective FCSRT AD CDR 0.5 to 1.0, DSM-IV 2
Larner (2007) Memory clinic, UK Case-control DemTect AD DSM-IV 2
deKoning et al. (2005) Stroke centres, the
Netherlands
Consecutive R-Camcog Post-stroke
dementia
DSM IV dementia, NINDS-AIREN 2
Borson et al. (2003) Community, USA Cohort Mini-Cog Dementia DSM IIIR, CDR 1 or more,
NINCDS criteria
2
Hogervortz et al. (2002) Outpatients, UK Case- control HVLT Dementia DSM IV, NINCDS-
ADRDA/NINDS-AIREN,
CERAD,
2
Kuslansky et al. (2002) Community, USA Cross-sectional MIS AD DSM-III-R, DSM-IV,
NINCDS-ADRDA
2
Smith et al. (2007) Memory clinic, UK Cohort MoCA Dementia ICD 10 2
Drachman et al. (1996) Clinic, USA Case-control CAST Dementia NINCDS-ADRDA 2
Basic et al. (2009) Clinics, Australia Consecutive RUDAS Dementia DSM IV 2
Mast et al. (2001) Outpatients, USA Cross-sectional FOME Dementia NINCDS-ADRDA 2
Mitchell. (2009) Primary and secondary care Meta-analysis MMSE Dementia NINCDS-ADRDA, DSM IV &
IIIR, ICD
2
Clionsky and Clionsky
(2010)
Specialist setting, USA Consecutive MOST Dementia DSM - IV 2
Hancock and Larner
(2010)
Memory clinics, UK Cross-sectional TYM Dementia DSM-IV, NINCDS-ARDRA and
other research diagnostic criteria
for subtypes
2
Hseish et al. (2013) Memory clinic, Australia Case-control ACE III AD, FTD Neuropsychological test, ACE-R 3
Mendiondo et al. (2003) Memory clinic, USA Case-control BAS AD CDR, MMSE 3
Mahoney et al. (2005) Community, UK Longitudinal TE4D-Cog test AD NINCDS ADRDA 3
Jitapunkul et al. (1991) In-patients, UK Consecutive AMT Dementia DSM IIIR 3
Pinto and Peters (2009) Primary and secondary care Literature
Review
CDT Dementia DSM IV, NINCDS-
ADRDA/NINDS-AIREN
3
Brooke et al. (1999) Outpatients, UK Case-control 6 CIT Dementia Global deterioration scale, MMSE 3
Solomon et al. (1998) Clinics, USA Case-control 7MS AD NINCDS-ADRDA, MMSE, Blessed
dementia rating scale
3
Kokmen et al. (1991) Inpatient and outpatient
settings, USA
Case-control STMS Dementia DSM III R, Mattis dementia scale 3
Salib and McCarthy
(2002)
Outpatients, UK Case control MAT Dementia NINCDS-ADRDA 4
AD = Alzheimer’s disease; PD-D = dementia with Parkinson’s disease, FTD = frontal temporal dementia. Please see Appendix for test abbreviations.
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Study characteristics and level of evidence
Table 1 presents the included papers with the
sources and study quality. One study met criteria
for the best LE (1) and 15 were rated 2 (Table 1).
Most studies were carried out in USA (9) and
Europe (9). Populations were usually specialist
settings including memory clinics (18), followed
by primary care (4), community (3) and hospital
in-patient settings (2). Table 2 summarizes the
tool characteristics. Table 3 gives the settings and
specific dementia subtypes for which the tests were
validated.
Results of individual studies
Brief descriptions of all tests follow (in alphabetical
order for each section):
TESTS VALIDATED IN BOTH PRIMARY CARE
AND SPECIALIST SERVICES
Addenbrooke’s Cognitive Examination (ACE). ACE
is a brief test sensitive to early dementia, and
differentiates dementia subtypes, including AD,
FTD, Parkinson’s disease dementia (PDD) and
progressive supranuclear palsy (PSP) (Mathuranath
et al., 2000; Reyes et al., 2009). The ACE includes
the MMSE but also frontal-executive and more
visuospatial items. The administration time is 16–
20 minutes. The naming component has ceiling
effects and the visuospatial component is relatively
limited.
A cut-off at 83 gave a sensitivity of 92% and
specificity of 90% in PDD, making the ACE
an appropriate instrument for the first-line global
evaluation of cognitive deficits in PD patients.
Further studies need to evaluate the ability of the
ACE to distinguish PDD from AD.
Addenbrooke’s Cognitive Examination Revised (ACE-
R). ACE-R was derived from ACE to facilitate
cross-cultural usage and improve sensitivity. The
original 26 components were combined to produce
five sub-scores, each representing a specific
cognitive domain: attention/orientation (18 points),
memory (26 points), fluency (14 points), language
(26 points), and visuospatial function (16 points)–
100 in total. It gives a cut-off score for the five sub-
domains against controls and takes between 12 and
20 minutes (average 16). The ACE-R sensitivity
to mild dementia (84% to 94% depending on cut
point) is better than the MMSE (Mioshi et al.,
2006). Three different alternative versions—A, B,
and C, with different stimuli for the name and
address recall, prevent recalling from previous tests.
A recent systematic search of ACE and ACE-R,
covering the period 2000 to April 2010, identified
nine studies but none of the studies included
in this review assessed inter-rater or intra-rater
reliability (Crawford et al., 2012). The authors also
highlight that there is lack of evidence on how those
with vascular dementia and Lewy Body dementia
perform on the ACE/ACE-R. A recent meta-
analysis which reviewed the diagnostic accuracy
of ACE and ACE-R reports that the ACE-R
has somewhat superior diagnostic accuracy to the
MMSE while the ACE appears to have inferior
accuracy and that the ACE-R is recommended in
both modest (primary care and general hospital
settings) and high prevalence settings (memory
clinics) (Larner and Mitchell, 2014).
Addenbrooke’s Cognitive Examination (ACE-III). In
light of weaknesses of certain domains in ACE-
R, such as repetition, comprehension, visuospatial,
items on the ACE-R were replaced to form
the ACE-III. The ACE-III continues to have a
maximum score of 100 and contain five cognitive
domains, but it is no longer possible to derive
the MMSE score. It was tested in 61 patients
with dementia (frontotemporal dementia, FTD,
n = 33, and Alzheimer’s disease, AD, n = 28)
and 25 controls. ACE-III cognitive domains was
found to correlate significantly with standardized
neuropsychological tests used in the assessment of
attention, language, verbalmemory and visuospatial
function and also compared very favorably with
its predecessor, the ACE-R, with similar levels
of sensitivity and specificity (Hsieh et al., 2013).
The two tests correlated significantly (r p = 0.99,
p < 0.01). The ACE-III also continues to show
high sensitivity and specificity at cut-offs previously
recommended: (1) 88 (sensitivity = 1.0; specificity
= 0.96) and (2) 82(sensitivity = 0.93; specificity =
1.0). Internal reliability of the ACE-III, measured
by Cronbach’s α coefficient, was 0.88. It needs
some training for administration and becoming
familiar with the instrument usually in terms of
hours. Larger studies with healthy older adults are
needed in the future for age- and education-specific
normative data. Also, authors suggest that utility
of the ACE-III in varying clinical settings (e.g.,
general neurology or memory clinics) needs to be
investigated and also compared with tests such as
RUDAS and MoCA (Hsieh et al., 2013).
Clock Drawing Test (CDT). The CDT is widely
used, quick and non-threatening (Shulman, 2000).
Probably the simplest scoring method employs a
six-point rating of drawing (Shulman, 2000). It does
not differentiate between Alzheimer’s disease (AD),
Dementia with Lewy Body (DLB), and cognitively
impaired Parkinson’s disease (PD) and there is little
sensitivity to change (Cahn-Weiner et al., 2003).
Validation studies are of low quality. The sensitivity
(76%) and specificity (81%) for CDT are low
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Table 2. Brief cognitive tests for dementia: administration times and screening performance (in alphabetical order)
NAME OF
THE TEST
TIME
TAKEN
(MIN)
TOTAL
SUBTESTS
OR ITEMS
TOTAL
SCORE
CUT-OFF
SCORE
(<) SN(%) SP (%) +LR -LR IRR TRR
SUITABLE FOR
VISUAL
IMPAIRED
............................................................................................................................................................................................................................................................................................................................................................................................................................................................
ACE 15–20 6 100 88 93 71 3.21 0.10 ɑ ɑ No
ACE-R 16 5 100 82 84 100  0.16 ɑ ɑ No
88 94 89 8.55 0.07
ACE-III 15 5 100 82 93 100  0.07 ɑ ɑ No
88 100 96 25 0
AMT < 10 10 10 8 91 75 3.64 0.36 ɑ ɑ Yes
BAS 3 4 39 26 96 98 48.0 0.02 ɑ ɑ Yes
CDT 1–3 1 10 7 76 78 4.00 0.3 0.88–0.97 0.94 No
CAST 15 40 43 36 88 100  0.12 ɑ 0.782 No
6CIT 5 6 24 8 79 100  0.21 ɑ ɑ Yes
Dem Tect 8–10 5 18 8 85 72 2.99 0.22 0.993 ɑ No
FCSRT 12–15 3 48 25 (free
recall)
78 90 7.80 0.24 ɑ ɑ No
48 47 (cued
recall)
54 90 5.40 0.6
FOME 15 1 50 19 91 97 30.3 0.11 ɑ ɑ Yes
HVLT <10 12 36 18/19 96 80 4.8 0.05 >0.99 ɑ Yes
MoCA 10 30 30 26 94 50 1.88 0.12 0.90 0.91 No
21 81 95 16.20 0.20
MMSE 12 11 30 24 87 82 4.83 0.16 0.97 0.887 No
MOST 5 4 29 18 85 76 3.54 0.20 0.9 0.91 No
7MS 6–11 4 0 92 96 23.0 0.09 0.93 0.91 No
MIS 4 4 8 4 80 96 20.0 0.14 ɑ ɑ No
Mini-cog 2–4 2 8 5 76 89 6.91 0.27 0.93–0.95 ɑ No
MAT 1 52 52 15 95 81 5.0 0.06 0.85 0.80 Yes
R-CAMCOG 10 25 49 34 66 92 8,25 0.37 ɑ ɑ No
37 83 78 3.77 0.22
RUDAS 10 6 30 23 88 90 8.77 0.13 0.99 0.98 No
STMS 5 8 38 3127
(age-
related)
86 92 13.29 0.15 ɑ ɑ No
TE4D-Cog 4–6 8 45 35 100 84 6.25 0 0.87 ɑ No
TYM 10 10 50 42 99 86 7.07 0.01 0.99 ɑ No
Sn = sensitivity; Sp = specificity; +LR = likelihood ratio positive; −LR = Likelihood ratio negative; IRR = Inter-Rater Reliability; TRR = Test–Retest Reliability; = insufficient or no
published data available.
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Table 3. Brief cognitive tests validated settings and speciﬁc dementia condition
i. Settings where validation tested
Primary care—GP practices
Mini-Cog, MIS, HVLT, CDT, MMSE, FCSRT
Specialist services: Memory clinics, community psychiatry services, neurology
MAT, MoCA, 6 CIT, CAST, HVLT, ACE/ACE-R, ACE-III, BAS, R-Camcog, Dem Tect, FOME, TYM, MOST,
RUDAS, TED4-Cog, 7MS, STMS
Acute hospital care services
AMT, R-Camcog
ii. Tests validated for specific dementia condition
Alzheimer’s disease—BAS, TE4D-Cog, Dem Tect, MIS, HVLT, FCSRT, TYM, 7MS, ACE III
Frontal lobe dementia—ACE III
Vascular—HVLT
Parkinson Disease Dementia—ACE, MoCA
Post stoke dementia—R-Camcog
and variable, possibly due to different patient and
control groups used (Pinto and Peters, 2009). The
test–retest reliability of CDT ranges from 0.87 to
0.94 and inter-rater reliability ranges from 0.82
to 0.97 depending on the scoring methods used
(Manos and Wu, 1994; Seigerschmidt et al., 2002).
Language and education influence the performance
of the CDT and its use in detecting early and
mild cases of dementia is limited (Pinto and Peters,
2009). Despite the various advantages of the CDT,
including its simplicity, speed of administration in
a busy practice and the potential to be less offensive
to patients, there are still many important aspects
that require further study (Pinto and Peters, 2009).
These issues include: the most appropriate scoring
system to be used, the training required by the
rater (naive vs. professional) and at what level
the test should be performed (general practitioner
vs. specialized service) (Shulman, 2000; Pinto and
Peters, 2009; Price et al., 2011).
Free and cued selective reminding test (FCSRT). In the
FCSRT, patients identify pictures (e.g., grapes,
vest) in response to category cues (fruit, clothing)
and are asked to recall them (free recall) and takes
about 10–15minutes. The category cues are used to
prompt recall of items not retrieved by free recall to
generate a score termed “cued recall” (Grober et al.,
2008). Total recall is the sum of free and cued recall.
Threemeasures derived from the FCSRThave been
proposed to detect dementia: free recall, total recall
and cue efficiency (the ratio of cued recall successes
to the number of cued recall attempts). FCSRT
has been tested both in community volunteers and
in memory disorder practices (Grober et al., 2008;
Grober et al., 2010). Free recall has 76% specificity
and sensitivities of 83% for AD and 74% for VaD
(Grober et al., 2008).
Hopkins Verbal Learning Test (HVLT). HVLT
assesses verbal recall and recognition with three
learning/free-recall trials followed by a recognition
trial (Rasmusson et al., 1995). It has six equivalent
forms, for reliable re-testing even at short intervals,
requires minimal training, is well-tolerated and
takes under 10 minutes. It does not have ceiling
effects and is not sensitive to educational levels
(Frank andByrne, 2000). TheHVLTdiscriminated
well between people with AD and controls, and
was useful in clinical and epidemiological practice.
In a district geriatric psychiatry service, HVLT
had better sensitivity (96%) when compared to
MMSE in detecting dementia with a cut off 18/19
and with high inter-rater reliability (>0.99) (Frank
and Byrne, 2000). However, in a community
dwelling population when tested between people
with dementia and without dementia controls
(including MCIs) at a cut-off of <16 the sensitivity
was 80% and specificity 84%. The sensitivity
increased to 90% at <18 with lower specificity
68%. Results were similar for both AD and VaD,
however, when combined with WRAT-R reading
(compromised in VaD), the specificity increased to
89% at a sensitivity of 90% (Kuslansky et al., 2004).
The cut-off score of 14.5 of the HVLT “total recall”
score showed a good discrimination between cases
and controls (sensitivity 87% and specificity 98%).
If the sensitivity needs to be higher, that is, for
research, then a higher cut-off for the “total recall”
of 19.5 or “memory” score with a cut-off point of
24.5 is suggested (Hogervorst et al., 2002).
Mini-Mental State Examination (MMSE). The
MMSE is a brief measure of cognitive functioning
and its change, taking 10 minutes by a trained
interviewer (Folstein et al., 1975). It is employed
extensively in clinical settings and studies and
needs some hours training and familiarizing
with the instrument. The MMSE has high test–
retest reliability, internal consistency and high
inter-observer reliability (Folstein et al., 1975).
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There are 11 items; with maximum score of 30
and cut-off score of 24, (accounting for age,
education, and language), with sensitivity of 87%
and specificity of 82% (Tombaugh and McIntyre,
1992). The MMSE is short, can be used by non-
specialists and its properties have been extensively
studied in different populations (Nilsson, 2007).
It lacks sensitivity in early dementia, FTD and
dementia with Lewy bodies (DLB). It does not
examine executive functions and there are few
episodic and semantic memory or visuospatial
tasks. Performance is affected by age, ethnicity and
limited education. Consequently, the cut-point may
need adjusting. For example, in highly educated
persons, a cut-off of 27 yielded a sensitivity of 69%
and specificity of 78% (PPV, 0.78; NPV, 0.86) for
identifying dementia (Nilsson, 2007).
A meta-analysis of 34 dementia and five MCI
studies using MMSE separated its use into high
and low prevalence settings (Mitchell, 2009). In
memory clinics the MMSE had a pooled sensitivity
of 80%, in mixed specialist hospital settings 71%,
in non-clinical community settings 85%, and in
primary care 78%.
Summary. MMSE, FCSRT, CDT, and HVLT
have been validated in both primary and specialist
care settings. HVLT with administration time less
than 10 minutes and high LR+ and low LR−
currently seem best suited for both primary and
secondary care settings and has better psychometric
properties than the commonly used MMSE but
has not been as extensively validated and only
incorporates the memory domain. ACE-R is
comparatively a longer test and therefore may only
be appropriate in those where the diagnosis is more
doubtful.
TESTS VALIDATED IN PRIMARY CARE
Mini-Cog. Mini-Cog, combines three-item word
memory and clock drawing; takes about 3 minutes
to perform; and was developed in a community
sample that over-represented people with dementia,
low education, non-white ethnicity and non-English
speakers (Borson et al., 2000). In a population-
based retrospective study, its effectiveness was
also compared with MMSE and a standardized
neuropsychological battery (Borson et al., 2003).
Mini-Cog may be used successfully by relatively
untrained raters as a first-stage dementia screen
and its inter-rater reliability is 0.93–0.95 (Scanlan
and Borson, 2001). It has lower sensitivity than the
MMSE at a cut-off point of 25 (76% vs. 79%)
and similar specificity (89% vs. 88%) for dementia
and therefore had little advantage although it was
shorter (Borson et al., 2003). The Mini-Cog may
not be appropriate for use with patients who are
visually impaired or have difficulty holding a writing
implement. There are no prospective tests of its
ability to detect dementia. Also the test has no value
in either monitoring disease progression or rating
severity.
Memory impairment screen (MIS). MIS comprises
four items, takes 4 minutes; and uses free and
cued-recall (Buschke et al., 1999). The subject is
asked to read the four target (to-be-remembered)
aloud from a printed page. Category cues are
presented then one at a time and subject are
asked to identify the target word that matched
the category-cue (e.g., FRUIT—PEACH). The
word sheet is then removed. After a non-sematic
interference task lasting 2–3 minutes, the subject is
asked to recall as many of the four target words as
possible (free recall) and presented with category
cues for items not recalled freely (cued recall).
Sensitivity was relatively low (80%) but specificity
was 96% using the optimal cut-off score of four,
in 438 English-speaking community volunteers
(11% with dementia). Age, education, and sex did
not significantly affect performance. MIS showed
superior sensitivity and specificity in comparison
with a three-item recall task in a population with
a similar dementia prevalence and authors suggest
validation in different cultural and socioeconomic
setting (Kuslansky et al., 2002).
Summary. Within primary care setting where phys-
icians are pressured for time, HVLT and MMSE
are longer with the HVLT having slightly better
psychometric properties. HVLT only incorporates
memory and uninformative about deficits in other
domains, therefore unlikely to be useful in other
dementias, such as frontal lobe dementias, FTLD,
and PDD. In a short consultation period, MIS,
taking about 4 minutes, with high LR+ and low
LR− is useful but sensitivity of only 80% means it
is not good at detecting dementia.
TESTS VALIDATED IN SPECIALIST
SERVICES: MEMORY CLINICS, COMMUNITY
PSYCHIATRY, NEUROLOGY, AND GENERAL
MEDICINE SERVICES
Abbreviated Mental Test (AMT). The Mental Test
Score (MTS) and its abbreviated version are brief
questionnaires to assess the degree of cognitive
function, particularly memory and orientation; the
MTS takes 10 minutes to administer, and the
abbreviated form (AMT) takes 3 minutes, is widely
used, particularly in UK primary care (Hodkinson,
1972). The AMT validity was evaluated in acute
geriatric ward inpatients with normal cognition,
dementia and delirium (Jitapunkul et al., 1991).
The best cut-off was 8/10 to differentiate normal
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from abnormal cognition including delirium, with
a sensitivity of (91%) but a low specificity of
75%. Although brief, the AMT does not effectively
test frontal/executive function. Although doctors
often use it without training, it is important that
it is interpreted the same way by all clinicians,
for example, whether questions should be replaced
or scored as missing or wrong in a variety of
circumstances. Patients do not have to read,
write, or draw anything to complete test, and so
completion of the AMT is not affected by visual
impairment, which is a common problem in older
people.
Brief Alzheimer screen (BAS). The BAS is a
brief test developed using logistic regression to
derive a predictive equation from MMSE and
category fluency items from assessments with 406
cognitively normal people and 342mild ADpatients
(Mendiondo et al., 2003). It has four components:
three item recall, date, spelling ‘World’ backwards
and category fluency, which altogether takes less
than 3 minutes and total maximum score of 39. In
validation samples, a cut-off score of 26 resulted in
99% sensitivity and 87% specificity. Patients who
scored between 23 and 26 need further cognitive
testing. Authors add that the screening test cannot
be considered diagnostic as many factors influence
the results of test such as population selection.
Of particular importance is the issue of education,
which is known to affect performance on spelling
“WORLD” backwards and may give false positive
and negative rates. It needs to be evaluated across
different populations and patients with dementia
subtypes. BAS do not need patient to read, write,
or draw anything to complete test, so can be used
in visually impaired.
Cognitive Assessment Screening Test (CAST). CAST is
a paper and pencil self- administered test, tested
in a small sample in a general medical clinic with
relatively low validity, designed to be completed
by older patients with at least some high school
education in about 15 minutes (Drachman et al.,
1996). CAST has 3 parts: Part A - ten simple
questions with 28 responses (e.g., writing own
name and address, copying a simple figure, etc.);
Part B -five more demanding questions with 12
scored responses (e.g., naming the Senators in own
state, etc.); and Part C - 13 questions regarding
subjective decline in memory and competence. It
takes minimal examiner time/training and there
was no significant change in test–retest scores
over a 12-month period (r = 0.782, p < 0.01)
(Drachman et al., 1996; Swearer et al., 2002).
However the authors conclude that the CAST,
like other brief screening tests, is not diagnostic
and designed to make an initial separation between
elderly patients with cognitive impairment from
those whose cognitive function is probably normal
(Swearer et al., 2002).
6-Item Cognitive Impairment Test (6CIT). The 6CIT
is a brief test taking less than 5 minutes (three
orientation items, count backwards from 20,
months of the year in reverse order, and learn an
address) which correlates highly (r2 = 0.911) with
the MMSE but was more sensitive in validation
at detecting mild dementia and is used in primary
care as well-being culturally unbiased (Brooke and
Bullock, 1999). It can be used in visual impaired
people to test their cognitive abilities (Rees et al.,
2010). However, the quality of the validation is
low. The number of items is low and therefore the
training time should be short.
DemTect. DemTect is a short (8 to 10 minutes) test
for dementia, comprising five short subtests (10-
word list repetition, number transcoding, semantic
word fluency task, backward digit span, delayed
word list recall) and its transformed total score
(maximum18) is independent of age and education.
It also has high test–retest and inter-rater reliability
(Kalbe et al., 2004). It is well accepted by
patients and requires little specific training to
administer. It is sensitive (85%) but not very
specific (72%) (Larner, 2007).The five subtests
cover immediate and delayed verbal recall, working
memory, language and number processing, and
executive functioning. It has only been validated
in a memory clinic population with high education
level and with FDG-PET as reference (Scheurich
et al., 2005; Larner, 2007).
Fuld object memory evaluation (FOME). FOME
evaluates encoding and retrieving ten unrelated
items across five immediate recall and a delayed
recall trial (Fuld et al., 1990). It is sensitive to
changes and can differentiate those with dementia
from community healthy controls (Fuld et al.,
1990). It is highly sensitive in nursing homes,
93% but specificity is low at 64% (Mast et al.,
2001). The performance of FOME is not influenced
by age, educational level and visual impairment
(Chung and W, 2009). It has excellent test–
retest reliability and parallel-form reliability, with
intraclass Correlation Coefficients ranging from
0.91 to 0.96 as tested in a Chinese population
(Chung, 2009).
Mental Alteration Test (MAT). TheMAT is modeled
on Trial Making Test and involves timed
performance of sequencing and category-switching
between numbers and letters (Salib and McCarthy,
2002). The maximum score is 52 points, with
cut-off of fewer than 15 correct alternations in
30 seconds. The test classifying correctly 95% of
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dementia cases if the MMSE scoring <24 on is
the gold standard. The false positive rate was 19%.
It can be used in visually impaired patients or in
those who have difficulty in using pen and paper
and has good reproducibility; test–retest correlation
(r = 0.80) and inter-rater reliability (r = 0.85, κ =
0.84) (Jones et al., 1993).
Montreal Cognitive assessment (MoCA). MoCA is a
10-minute; 30-point cognitive test with executive
functioning and attention tasks designed for those
scoring 24–30 on MMSE (Smith et al., 2007).
The suggested cut-off is 26 and it has adequate
test–retest reliability (Nasreddine et al., 2005). It
was prospectively validated in a UK memory clinic
setting to determine its usefulness as a predictive
tool for developing dementia (Smith et al., 2007). At
6-month follow-up MoCA detected mild dementia
in people withMCI (MMSE score above 25 points)
with 94% sensitivity and 50% specificity. MoCA
has excellent sensitivity (97%) for detecting MCI
and MCI/AD combined but poor specificity (35%)
using cut-score of 26 or below (Luis et al., 2009).
MoCA is also accurate in PD, with cut-offs of
21/30 for PDD (sensitivity 81%; specificity 95%;
negative predictive value 92%) (Dalrymple-Alford
et al., 2010).
Memory Orientation Screening Test (MOST). MOST
combines three-word recall, time orientation, list
memory and CDT, taking under 5 minutes and
maximum score of 29 (Clionsky and Clionsky,
2010). Developed and validated in old age
psychiatry settings, MOST was more sensitive
than MMSE and Mini-cog for detecting dementia
(Clionsky and Clionsky, 2010). The MOST
demonstrated very high test–retest reliability over
a brief interval (mean = 66 days, SD = 61.4) with
a Pearson r = 0.91 (p < 0.001) and high test–retest
reliability (r = 0.62–0.77) over a longer interval
(mean = 9.2 months, SD = 4.4 months), and
inter-rater reliability was r = 0.9, which was not
examined directly (Clionsky and Clionsky, 2010).
MOST requires validation in other settings and
diverse population.
Rotterdam-CAMCOG (R-CAMCOG). In this in-
strument, CAMCOG, the cognitive part of the
Cambridge Examination for Mental Disorders of
the Elderly was adapted to reduce administration
time to ten minutes, and to improve diagnostic
accuracy (de Koning et al., 2005). The R-
CAMCOG contains 25 items testing orientation,
memory (recent, remote, and learning), perception
and abstraction. It can be used without confounding
by paresis or mild aphasia but has unacceptable
trade-offs between specificity and sensitivity. It
is unsuitable for moderate to severe aphasia,
visually impaired and lacks executive items, which
are important for subcortical vascular deficits (de
Koning et al., 2005). This test requires accessories,
such as a picture-book, which may limit its used
in routine clinical practice. Training should be
relatively easy and be completed in hours.
Rowland Universal Dementia Assessment scale (RU-
DAS). RUDAS was designed as a multicultural
cognitive assessment scale and validated in an
Australian community sample, measuring memory,
gnosis, praxis, visuospatial skills, judgement and
language (Storey et al., 2004). It takes ten minutes
to administer, requiring minimal training and
with high inter-rater (0.99) and test–retest (0.98)
reliabilities (Storey et al., 2004). Validation in a
community dwelling persons recruited from clinics
and healthcare programs showed a cut-off score
of 23/30 had 88% sensitivity and 90% specificity
(Basic et al., 2009). RUDAS is relatively unaffected
by gender, education and first language. However,
an education bias emerged in a Malayalam
translated RUDAS in a South Indian population
(Iype et al., 2009).
Seven minute screen test (7MS). 7MS consists of
4 tests; Benton temporal orientation, enhanced
cued recall, clock drawing and verbal fluency tasks
(Solomon and Pendlebury, 1998). It is brief and
unbiased by education or age. It takes a mean
of 7 minutes 42 seconds (range 6–11 minutes)
to administer by a trained interviewer. It requires
minimal training. The overall test–retest reliability
for the battery of tests was high (r = 0.91),
and inter-rater reliability was high (r = 0.93)
(Solomon and Pendlebury, 1998). It was useful in
discriminating persons with AD from cognitively
intact with sensitivity of 92% and specificity of 96%
(Solomon et al., 1998). There have been number of
validation studies in other languages including for
other dementias (Meulen et al., 2004; Ijuin et al.,
2008).
Short Test of Mental Status (STMS). Short Test of
Mental Status can be administered in inpatient
and outpatient settings in approximately 5 minutes,
and tests orientation, attention, immediate recall,
arithmetic, abstraction, construction, information,
and delayed (approximately 3 minutes) recall
(Kokmen et al., 1991). The test was administered
to a group of community patients with a diagnosis
of dementia and age- and sex-matched controls.
Using an age-adjusted approach, sensitivity of the
test to identifying dementia is 86%, with a specificity
of 94%. The STMS appeared to be modestly
influenced by age and education, with correlations
of−0.34 (p= .0001) for age and 0.41 (p= 0.0001)
for education. The study authors additionally noted
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that a severe language disturbance would preclude
the use of the STMS.
Test your memory test (TYM). TYM is a 10-item
test, self-administered under medical supervision,
scoring from 0 to 50 (Brown et al., 2009). Although
it is suggested it is self-completed it requires the
clinician to be present and so we regard it as
face to face. Inter-rater agreement for scoring
is excellent and ten minutes’ training and the
scoring sheet allowed a nurse, without experience
of memory clinics, to score the TYM sheets as
accurately as a specialist (Brown et al., 2009).
It includes orientation, copying, retrograde and
anterograde memory, calculation, phonemic verbal
fluency, similarities, object naming, visuospatial,
and executive function. It was specific and sensitive
for the diagnosis of AD and to detect more cases
of AD than MMSE in highly educated patients
in a memory clinic, including those with sensory
impairments such as hearing impairment and in
situations where clinician time is limited (Hancock
and Larner, 2011). It requires further validation in
diverse education, cultural, and care setting.
Test for the early detection of dementia (TE4D-Cog).
Initially developed in Germany (known as TFDD)
(Ihl et al., 2000), it was modified for use in
an English-speaking population (Mahoney et al.,
2005). This eight-item test is scored out of 45
and has seven subscales: immediate recall, semantic
memory, CDT, category fluency, orientation to
time and ideomotor praxis. A cut-off of 35 gives
sensitivity of 100% and specificity of 84%, in
differentiating early dementia from non-dementia.
The TE4D-Cog is age, gender, and education
independent in people with mild dementia. It
also had good concurrent validity, high inter-
rater reliability, good internal consistency, can
detect change and requires minimal training
(Mahoney et al., 2005). It requires further
evaluation in memory clinics and non-English-
speaking populations.
Summary. Amongst the tests validated in secondary
care, BAS and TE4D-cog have good sensitivity
and specificity to detect dementia, but need more
extensive validation and longitudinal studies. 6CIT
is rapid and has good psychometric properties
(less than 5 minutes) but requires more extensive
validation studies in communities with different
demographic characteristics. The TYM and 7MS
look promising but need much more evidence.
RUDAS (longer but more sensitive) does not
require literacy andmay bemore useful in those who
are illiterate in English. R-CAMCOG is useful for
some post-stroke dementia. Like ACE, MoCA are
useful to detect dementia with Parkinson’s disease,
and for more detailed testing for those scoring
relatively highly in shorter cognitive tests.
Discussion
The review evaluates the 22 face-to-face cognitive
tests for people with suspected dementia, which
take 20 minutes and for which data on diagnostic
validity are available. The upper limit of 20 minutes
includes tests suitable for secondary care, including
memory clinics, and no tests of such duration are
suggested for primary care. These tests are only part
of a diagnostic process which also includes history
and examination of mental state. The papers do not
specify which health professionals can use them but
our clinical experience suggests they can be used by
nurses, psychologists and doctors and the highest
level skill in their use is more in the interpretation
rather than the administration.
The MMSE is currently the most widely-used
brief cognitive test, in routine clinical practice.
Psychological Assessment Resources (PAR) holds
the exclusive licence for this instrument, to publish,
distribute, and manage all intellectual property
rights (Martin and O’Neill, 2009). This copyright is
now being enforced, at $1.23 per test (Newman and
Feldman, 2011). It is particularly timely to explore
the alternatives, to see if it can be replaced in routine
practice (Newman and Feldman, 2011).
The Hopkins Verbal Learning Test (HVLT) has
been validated both in primary care and specialist
care settings, especially for AD. It takes less than
ten minutes and has high LR+ and low LR−. It has
better psychometric properties than the MMSE. It
is currently being validated in developing countries,
for example, East Asia (Hogervorst, 2011). The
HVLT-revised is also copyrighted by NPAR but
not the HVLT. In primary care, where time is
very limited for the individual patient, the 6-
CIT has potential. It takes less than five minutes
(three orientation items, count backwards from 20,
months of the year in reverse order, and learn an
address). It correlates highly with the MMSE but
was more sensitive in detecting mild dementia in
primary care as well-being culturally unbiased but
the quality of the validation is low. The TE4D-
cog has the highest sensitivity with a reasonable
specificity of 84%, and TYM, 7MS, CAST, and
BAS also have good psychometric properties. All
require further validation.
Among the validation studies, the review on
ACE/ACE-R cognitive test yielded the highest level
of evidence, which concluded the ACE-R is a robust
tool for discriminating between dementia and non-
dementia in clinic settings (Crawford et al., 2012).
The newly developed version ACE-III does not
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have the MMSE embedded. A recent report shows
that it is valid cognitive test for detecting dementia
syndromes—AD and FTLD (Hsieh et al., 2013).
ACE-R has better diagnostic accuracy than ACE
and MMSE, and is recommended in both modest
(primary care and general hospital settings) and
high prevalence settings (memory clinics) (Larner
and Mitchell, 2014).
In acute hospital care there are no instruments
which have high sensitivity and specificity and
further work is required. 6CIT has been tested for
cognitive impairment in general hospital setting,
but needs validation for dementia screening (Tuijl
et al., 2012). A recent study which compared
AMT4 with AMT10 and 6CIT cognitive tests
opined that additions of tests of short-term memory
such as 6CIT with AMT4 are needed to enhance
accuracy for detection of cognitive impairment
(Locke et al., 2013). The Cognitive Performance
Score (CPS2), which combines data from 5 items
from the interRAI Acute Care (interRAI AC)
(Gray et al., 2008), an instrument which assesses
12 domains including cognition, physical and
psychosocial functioning, appears to be another
useful screening tool for assessing for dementia in
acutely unwell older hospitalized patients (Travers
et al., 2013). However, the CPS2 has not been
validated as a stand-alone instrument—while the
CPS2 takes less than 5 minutes to be administered,
it has to be administered as part of the full interRAI
AC assessment which usually takes between 40 and
60minutes depending on the complexity of the case.
To our knowledge, this is the first review of brief
cognitive tests with a broad remit and which has
categorized tests according to the confidence with
which we can use them in the setting for which
they were designed. This review focuses on patients
with mild stage of dementia minimizing variation
in patient population and on cognitive tests with
the best available level of evidence. This allows for
reasonable comparison of the diagnostic accuracy
of the instruments.
Limitations. We have tried in to account for the
bias in patient samples and specify when further or
different validation is needed but lack of evidence of
validity in different clinical settings is not evidence
of lack of validity. Also there may be good evidence
of validation but the test may not be that effective,
such as MIS (Kuslansky et al., 2002). We have
focussed on dementia. For the sake of clarity
and not tried to review papers for mild cognitive
impairment and therefore our findings cannot be
generalized to it—We have commented only on
those studies which were English language of face
to face tests for those with suspected dementia
and with validation data. This means we have
excluded those, where there were no validation
studies, for example, Epidemiological Dementia
Index; those for assessing moderate to severe
AD, for example, Severe cognitive impairment
rating scale; taking longer, for example, Alzheimer
Disease Assessment Scale-Cognitive; requiring an
informant questionnaire, for example, The General
Practitioner assessment of Cognition; those with
no cut-off scores and specificity and sensitivity, for
example, Brief Kingston Standardized Cognitive
Assessment—revised, Biber Cognitive Estimation
Test; those validated in non-English languages, for
example, Short and sweet screening instrument,
time and change test, Short Cognitive Battery;
and those carried out via telephone, for example,
Telephone Interview for Cognitive Status (Table
S1).This does not imply that these tests are not
valid. The review excluded translated versions of the
tests and a future review of those would be desirable.
We have estimated training time from our clinical
experience but it is usually not specified and when
the authors comment it needs minimal training it
is unclear in which group. We think that most tests
require very short training times measured in hours
rather than days for clinicians without experience in
this field and less for experienced clinicians.
Validation papers do not treat psychometric tests
like drugs and do not report “side-effects” of the use
of instruments and longer tests may distress people
more, particularly if they do badly in them, as well
as being impractical in resource terms. As always
it is essential that clinicians are sensitive and do
not persist in these circumstances unless there is
unequivocal benefit.
There are few studies comparing multiple
instruments. It is important to consider that
results of cognitive tests can be influenced by
various factors such as selection population with
performance inflated by high rates of dementia
in the study sample, by high average severity of
cognitive impairment among affected persons, or
spectrum bias, that is, the participants are often
not consecutive patients, for example, those without
dementia are a convenience sample (Mahoney
et al., 2005). The reference tests in many of these
studies exhibit incorporation bias, where the index
and reference tests are not independent such as
CDT, Mini-Cog, BAS, MOST, 7MS, TE4D-Cog
(Borson et al., 2003; Mendiondo et al., 2003; Ijuin
et al., 2008; Pinto and Peters, 2009; Clionsky and
Clionsky, 2010). The reference test standard is
often concurrent clinical diagnosis which although
using standard criteria is not neuropathologically
validated.
It is very difficult to apply levels of evidence
to markedly difficult study designs (varying from
case control to systematic reviews) and while
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we have used standardized independent criteria
in a transparent fashion to produce judgments
about the comparative evidence for papers this is
not definitive. Some of the criteria are arguable,
for example, a systematic review ranks above an
individual study but it can be the case that a
beautifully carried out research project, has more
accurate information than a systematic review
which incorporates less good papers. Nonetheless
our study organizes and adds to the information
available and is transparent enough to allow
readers to draw their own conclusions. Each of
these diagnostic tests would require diagnostic test
accuracy review in its own right and available for
few tests, such as ACE/ACE-R, MMSE, and CDT
(Mitchell, 2009; Pinto and Peters, 2009; Larner and
Mitchell, 2014).
Conclusions
While many brief dementia tests are available,
few are widely used, and many have limited
evidence regarding their performance. Despite its
limitations, MMSE is still the most commonly
used, and is also used as a reference standard
within most validation studies. Now that there are
to be significant costs associated with its use, it
is important to examine whether it is the best
instrument available. We have highlighted tests
with better psychometric properties. Practitioners
need to use tests as appropriate to the setting
and individual patient, since the resources (e.g.,
time and personnel) and goals for use of the
cognitive test differs. A stepped approach may be
appropriate with the use in specialist settings of a
short instrument followed by a longer one. There
is need for further robust validation of available
tests in varied populations for different dementia
syndromes, rather than development of new ones
(Milne et al., 2008).
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Appendix. Abbreviations of the tools (in alphabetical order)
ABBREVIATIONS
AD Alzheimer’s disease
ACE-R Addenbrooke’s Cognitive Examination Revised
ADAS-Cog Alzheimer’s Disease Assessment Scale-cognitive subscale
AMTS Abbreviated Mental Test score
BAS Brief Alzheimer Screen
BDS-cog Blessed Dementia Scale
6CIT 6 Item Cognitive Impairment Test
CAST Cognitive Assessment Screening Test
CDT Clock Drawing Test
CDR Clinical Dementia Rating
CERAD Consortium to Establish a Registry for Alzheimer’s Disease
Dem Tect Dementia Detection
DSM III-R Diagnostic and Statistical Manual of Mental Disorders, third edition, revised
DSM IV Diagnostic and Statistical Manual of Mental Disorders, fourth edition
FCSRT Free and cued selective reminding test
FOME Fuld object memory evaluation
HVLT Hopkins Verbal Learning Test
ICD 10 International Classification of Diseases, 10th revision
MAT Memory alteration test
MIS Memory impairment screen
MMSE Mini-Mental State Examination
MoCA Montreal cognitive assessment
MOST Memory Orientation Screening Test
MDS Movement Disorders Task Force criteria
7MS 7 minute screen
NINCDS-ADRDA National Institute of Neurological and Communicative Disorders and Stroke and the
Alzheimer’s Disease and Related Disorders Association
NINDS-AIREN National Institute of Neurological Disorders and Stroke (NINDS) and the Association
Internationale pour la Recherche et l’Enseignement en Neurosciences (AIREN)
PD-D Dementia with Parkinson’s Disease
R-CAMCOG Rotterdam- the cognitive and self-contained part of the Cambridge Examination for Mental
Disorders of the Elderly
RUDAS Rowland Universal Dementia Assessment scale
TE4D-Cog Test for the early detection of dementia
TYM Test Your Memory
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